Amgen (AMGN) Tmuɣli n wazal
Ṛṛbem n lḥedd$414.74Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel+2.14%
Asnulfu n AI: AMGN
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Amgen Inc. is an independent biotechnology pharmaceutical company that discovers, develops, manufactures, and markets medicines for serious diseases. The company focuses on patient care and the development of new drugs based on cellular and molecular biology.
